Related Experiment Video
Updated: Jul 27, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
The promise of retinoids to fight against cancer
1Dipartimento di Patologia Generale e Oncologia, Seconda Università degli Studi di Napoli, Italy. lucia.altucci@unina2.it
Abstract:
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Insights
Retinoids can be harmful or helpful, acting as teratogens but also suppressing tumors. Understanding their anti-proliferative mechanisms offers potential for cancer therapy and prevention.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Retinoids exhibit dual properties, acting as teratogens while possessing tumor-suppressive capabilities.
- Significant advancements in cell biology and genetics have enhanced understanding of retinoid mechanisms.
Purpose of the Study:
- To explore the anti-proliferative actions of retinoids.
- To elucidate pathways activated by retinoids for therapeutic applications.
Main Methods:
- Review of cell biology and genetic studies on retinoid mechanisms.
- Analysis of retinoid-activated pathways.
Main Results:
- Retinoids demonstrate anti-proliferative effects.
- Specific pathways activated by retinoids have been identified.
Conclusions:
- Understanding retinoid pathways can lead to novel cancer therapies.
- Retinoids hold promise for cancer prevention strategies.
More Related Videos
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
08:18Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
Published on: October 4, 2024
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...